Patient education: what is the cold chain for biosimilars and biologics?
The cold chain is an essential aspect of pharmaceutical distribution in Canada. A cold chain is a series of temperature-controlled facilities, vehicles, and procedures that ensure the safe transportation and storage of pharmaceutical products. The maintenance of a cold chain is vital to protect the…
The importance of patient education and awareness campaigns around biosimilars to reduce stigma in Canada
Biosimilars are a type of biological medication that are highly similar to an existing biologic drug. These medications have the potential to provide more affordable and accessible treatment options for patients in Canada, yet uptake has been slower than expected. Patient education and awareness campaigns…
The impact of biosimilars on the biopharmaceutical industry and their potential to promote innovation
The biopharmaceutical industry is an essential component of the global healthcare system, providing life-saving treatments for a wide range of conditions. However, the high cost of many biologic drugs has become a significant challenge for patients, healthcare providers, and payers alike. The introduction of biosimilars…
How clinics manage care for patients taking biologics
Biologics are a powerful tool for treating serious and life-threatening medical conditions, but managing a chronic condition with biologics can be challenging. To help patients receive the best possible care, clinics have implemented various strategies and technologies to manage patient care for patients taking biologics….
